검색어 : 통합검색[649.1]
총 1,196건 중 1,000건 출력
, 18/100 페이지
-
171
- Book Review Autism Spectrum Disorders in Infants and Toddlers: Diagnosis, Assessment, and Treatment Edited by Katarzyna Chawarska, Ami Klin, and Fred R. Volkmar. 348 pp. New York, Guilford Press, 2008. $42. 978-1-59385-649-6
- Enahoro, Rita; ; (The New England journal of medicine, v.359, 2008, pp.1300-1301)
-
172
- Multiphase Science and Technology, Volume 4 : edited by G. F. Hewitt, J. M. Delhaye and N. Zuber; published by Hemisphere Publ. Corp., New York, 1989; price £67.00; ISBN 0-89 116-649-1
- Mewes, D.; ; (Chemical engineering and processing = Génie des procédés = Verfahrenstechnik, v.27, 1990, pp.115-115)
-
173
- Incubation time and culture media impact success of identification of <i>Nocardia</i> spp. by MALDI-ToF mass spectrometry
- McTaggart, Lisa R.; Chen, Yan; Poopalarajah, Rahgavi; Kus, Julianne V.; Corresponding author. Tel.: +1-647-792-3171; fax: +416-649-4512.; (Diagnostic microbiology and infectious disease, v.92, 2018, pp.270-274)
-
174
- Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium
- Le Meur, G; Stieger, K; Smith, A J; Weber, M; Deschamps, J Y; Nivard, D; Mendes-Madeira, A; Provost, N; Pé ré on, Y; Cherel, Y; Ali, R R; Hamel, C; Moullier, P; Rolling, F; [1] 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France [2] 2CHU Hotel-Dieu, Service d'Ophtalmologie, Nantes, France; 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France; 3Division of Molecular Therapy, Institute of Ophthalmology, University College of London, London, UK; [1] 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France [2] 2CHU Hotel-Dieu, Service d'Ophtalmologie, Nantes, France; 4Ecole Nationale Vé té rinaire de Nantes, Service d'urgences, Nantes, France; 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France; 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France; 1INSERM U649, CHU Hotel-Dieu, Nantes Cedex, France; 5CHU Hotel-Dieu, Laboratoire d'Exploration fonctionnelle, Nantes, France; 6INRA UMR 703, Ecole Nationale Vé té rinaire de Nantes, Nantes, France; 3Division of Molecular Therapy, Institute of Ophthalmology, University College of London, London, UK; 7INSERM U583, Hô pital Saint-Eloi, Institut des Neurosciences de Montpellier, Montpellier,; (Gene therapy, v.14, 2007, pp.292-303)
-
175
- Linolenic Acid as the Main Source of Acrolein Formed During Heating of Vegetable Oils
- Endo, Yasushi; Hayashi, Chieko; Yamanaka, Takashi; Takayose, Koichi; Yamaoka, Miki; Tsuno, Takuo; Nakajima, Shigeo; School of Bioscience and Biotechnology Tokyo University of Technology 1404‐ 1 Katakura Hachioji Tokyo 192‐ 0982 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; Tsuno Food Industrial Co. Ltd 94 Shinden, Katsuragi Ito Wakayama 649‐ 7194 Japan; (Journal of the American Oil Chemists' Society : JAOCS, v.90, 2013, pp.959-964)
-
176
- Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine
- St-Pierre, Jacques-André ; Bé dard, Paul J.; Department of Pharmacology, Laval University and Centre de Recherche en Neurobiologie, Hô pital de l'Enfant-Jé sus, 1401, 18e rue, Qué bec (Qué bec, Canada, G1J 1Z4; Corresponding author. Tel. (418) 649-5593, fax (418) 649-5910.; (European journal of pharmacology, v.272, 1995, pp.123-129)
-
177
- Vegetable Production and Marketing in Africa: Socio-Economic Research. Edited by D Mithofer and H. Waibel. Wallingford, UK and Cambridge, MA: CABI (2011), pp. 288, £85.00/US$160.00. ISBN 978-1-84593-649-5.
- Martin, Adrienne; ; (Experimental agriculture, v.48, 2012, pp.602-602)
-
178
- First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis with 3-year follow-up.
- Shen, Lin; Bai, Yuxian; Lin, Xiaoyan; Li, Wei; Wang, Jufeng; Zhang, Xiaochun; Pan, Hongming; Bai, Chunmei; Bai, Li; Cheng, Ying; Zhang, Jingdong; Zhong, Haijun; Ba, Yi; Hu, Wenwei; Xu, Rui-hua; Guo, Weijian; Qin, Shukui; Wang, Rui; Sullivan, Kendall; Liu, Tianshu; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China; ; Herbin Medical University, Heilongjiang, China; ; Fujian Medical University Union Hospital, Fuzhou, China; ; The First Hospital of Jilin University, Changchun City, China; ; Henan Cancer Hospital, Zhengzhou, China; ; The Affiliated Hospital of Qingdao University, Qingdao, China; ; Sir Run Run Shaw Hospital, Hangzhou, China; ; Department of Oncology, Peking Union Medical College Hospital, Beijing, China; ; China PLA General Hospital (301 Hospital), Beijing, China; ; Jilin Cancer Hospital, Changchun, China; ; Liaoning Cancer Hospital and Institute, Shenyang, China; ; Zhejiang Cancer Hospital, Hangzhou, China; ; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; ; The First People's Hospital Of Changzhou, Changzhou, China; ; Medical Oncology Cancer Center, Sun Yat-Sen University, Guangzhou, China; ; Fudan University; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.41, 2023, pp.353-353)
-
179
- 419P Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Additional analyses from 4-year (y) follow-up (FU) of CheckMate 649
- Wyrwicz, L.S.; Shitara, K.; Moehler, M.; Ajani, J.A.; Shen, L.; Garrido, M.; Araneda, C.E. Gallardo; Yamaguchi, K.; Cleary, J.; Elimova, E.; Maya, R. Brugé s; Karamouzis, M.V.; Skoczylas, T.; Bragagnoli, A.C.; Liu, T.; Tehfe, M.; Feeney, K.; Wang, R.; Zhang, J.; Janjigian, Y.Y.; ; (Annals of oncology : official journal of the European Society for Medical Oncology, v.35, 2024, pp.S169-S170)
-
180
- First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis 4-year (yr) follow-up.
- Shen, Lin; Bai, Yuxian; Lin, Xiaoyan; Li, Wei; Wang, Jufeng; Zhang, Xiaochun; Pan, Hongming; Bai, Chunmei; Bai, Li; Cheng, Ying; Zhang, Jingdong; Zhong, Haijun; Ba, Yi; Hu, Wenwei; Xu, Rui-Hua; Guo, Weijian; Qin, Shukui; Wang, Rui; McCraith, Stephen; Liu, Tianshu; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China; Herbin Medical University, Heilongjiang, China; Fujian Medical University Union Hospital, Fuzhou, China; The First Hospital of Jilin University, Changchun City, China; Henan Cancer Hospital, Zhengzhou, China; The Affiliated Hospital of Qingdao University, Qingdao, China; Sir Run Run Shaw Hospital, Hangzhou, China; Peking Union Medical College Hospital, Beijing, China; China P.L.A. General Hospital (301 Hospital), Beijing, China; Jilin Cancer Hospital, Changchun, China; Liaoning Cancer Hospital and Institute, Shenyang, China; Zhejiang Cancer Hospital, Hangzhou, China; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; The First People's Hospital of Changzhou, Changzhou, China; Medical Oncology Cancer Center, Sun Yat-Sen University, Guangzhou, China; Fudan University Shanghai Cancer Center, Shanghai, Ch; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.318-318)
QUICK MENU
